We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVLT icon
251
Commault Systems
CVLT
$5.14B
$1.23M 0.1%
16,456
+9,850
+149% +$771K
UVE icon
252
Universal Insurance Holdings
UVE
$1.22B
$1.23M 0.1%
84,672
+15,686
+23% +$151K
TECH icon
253
Bio-Techne
TECH
$11.2B
$1.22M 0.1%
51,672
-7,324
-12% -$159K
BPL
254
DELISTED
Buckeye Partners, L.P.
BPL
$1.22M 0.1%
17,195
+7,351
+75% +$495K
NXPI icon
255
NXP Semiconductors
NXPI
$56.4B
$1.22M 0.1%
26,548
-27,796
-51% -$1.14M
FTK icon
256
Flotek Industries
FTK
$950M
$1.22M 0.1%
10,118
+1,338
+15% +$170K
JEF icon
257
Jefferies Financial Group
JEF
$12.8B
$1.22M 0.1%
47,943
+14,989
+45% +$379K
PNW icon
258
Pinnacle West Capital
PNW
$12.1B
$1.22M 0.1%
22,962
+9,574
+72% +$524K
BFX
259
DELISTED
BowFlex Inc.
BFX
$1.22M 0.1%
144,161
-7,180
-5% -$54.3K
LMNX
260
DELISTED
Luminex Corp
LMNX
$1.21M 0.1%
62,566
+2,569
+4% +$48.6K
THG icon
261
Hanover Insurance
THG
$8.08B
$1.21M 0.1%
20,288
+12,588
+163% +$742K
PACR
262
DELISTED
PACER INTL INC TENN
PACR
$1.21M 0.1%
146,536
-43,800
-23% -$340K
TBRG
263
DELISTED
TruBridge
TBRG
$1.21M 0.1%
19,541
-5,052
-21% -$305K
ESND
264
DELISTED
Essendant Inc.
ESND
$1.21M 0.1%
26,259
-1,177
-4% -$51.7K
MENT
265
DELISTED
Mentor Graphics Corp
MENT
$1.21M 0.1%
50,077
+4,009
+9% +$90.6K
TROW icon
266
T. Rowe Price
TROW
$24.1B
$1.2M 0.1%
14,373
-8,188
-36% -$641K
TRI icon
267
Thomson Reuters
TRI
$44.4B
$1.2M 0.1%
27,402
+21,882
+396% +$934K
AMRI
268
DELISTED
Albany Molecular Research Inc
AMRI
$1.2M 0.09%
119,014
+7,545
+7% +$91.2K
KEY icon
269
KeyCorp
KEY
$24.4B
$1.2M 0.09%
89,347
-213,979
-71% -$2.71M
TA
270
DELISTED
TravelCenters of America LLC
TA
$1.2M 0.09%
24,582
-1,740
-7% -$79.8K
ARW icon
271
Arrow Electronics
ARW
$11.1B
$1.2M 0.09%
22,040
-261
-1% -$13.3K
SPLK
272
DELISTED
Splunk Inc
SPLK
$1.2M 0.09%
17,417
+2,249
+15% +$146K
CIEN icon
273
Ciena
CIEN
$55.1B
$1.19M 0.09%
49,664
+2,965
+6% +$70.6K
DNR
274
DELISTED
Denbury Resources, Inc.
DNR
$1.19M 0.09%
72,220
+31,552
+78% +$557K
LEA icon
275
Lear
LEA
$6.36B
$1.19M 0.09%
14,649
-13,189
-47% -$1.03M
9 10
11
12 13

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.